Mitoxantrone April 12, 2017 Mitoxantrone Trade Name Novantrone Orphan Indication Hormone refractory prostate cancer USA Market Approval USA USA Designation Date 1996-08-21 00:00:00 Sponsor Serono;One Technology Place;Rockland, Massachusetts, 02370